Downloads provided by UsageCounts
Besides transformed cells, the tumors are composed of various cell types that contribute to undesirable tumor progression. Tumor-associated macrophages (TAMs) are the most abundant innate immune cells in the tumor microenvironment (TME). Within the TME, TAMs exhibit high plasticity and undergo specific functional metabolic alterations according to the availability of tumor tissue oxygen and nutrients, thus further contributing to tumorigenesis and cancer progression. Here, we review the main functional TAM metabolic patterns influenced by TME, including glycolysis, amino acid, and fatty acid metabolism. Moreover, this review discusses antitumor immunotherapies that affect TAM functionality by inducing cell repolarizing and metabolic profiles towards an antitumoral phenotype. Also, new macrophage-based cell therapeutic technologies recently developed using chimeric antigen receptor bioengineering are exposed, which may overcome all solid tumor physical barriers impeding the current adoptive cell therapies and contribute to developing novel cancer immunotherapies.
Energy metabolism/drug effects, T-Lymphocytes, 610, Review Article, Immunotherapy, Adoptive, RC0254, SDG 3 - Good Health and Well-being, Neoplasms, Receptors, Tumor-Associated Macrophages, Tumor Microenvironment, Animals, Humans, Tumor microenvironment/immunology, Genetic therapy/adverse effects, Immune Checkpoint Inhibitors, RC254-282, MCC, Receptors, Chimeric Antigen, QH573-671, RC0254 Neoplasms. Tumors. Oncology (including Cancer), adoptive/adverse effects, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Genetic Therapy, T-Lymphocytes/immunology, Neoplasms/genetics, chimeric antigen/genetics, Phenotype, Immune checkpoint inhibitors/adverse effects, Tumor-associated macrophages/drug effects, Immunotherapy, Cytology, Energy Metabolism
Energy metabolism/drug effects, T-Lymphocytes, 610, Review Article, Immunotherapy, Adoptive, RC0254, SDG 3 - Good Health and Well-being, Neoplasms, Receptors, Tumor-Associated Macrophages, Tumor Microenvironment, Animals, Humans, Tumor microenvironment/immunology, Genetic therapy/adverse effects, Immune Checkpoint Inhibitors, RC254-282, MCC, Receptors, Chimeric Antigen, QH573-671, RC0254 Neoplasms. Tumors. Oncology (including Cancer), adoptive/adverse effects, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Genetic Therapy, T-Lymphocytes/immunology, Neoplasms/genetics, chimeric antigen/genetics, Phenotype, Immune checkpoint inhibitors/adverse effects, Tumor-associated macrophages/drug effects, Immunotherapy, Cytology, Energy Metabolism
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 15 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 36 | |
| downloads | 75 |

Views provided by UsageCounts
Downloads provided by UsageCounts